REVLIMID Drug Use Examination
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- Sponsors Celgene Corporation
- 30 Nov 2017 Status changed from active, no longer recruiting to completed.
- 24 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 24 Sep 2015 New trial record